This inventor holds 10 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: The University of Queensland, Xenome Limited, The University of Sydney. Active years: 2004-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Woolloogabba, AU (2006)
- Woolloongabba, AU (2004 - 2011)
- Wooloongabba, AU (2012 - 2014)
- Parrearra, AU (2020)
Company Filing History:
5 out of 345 
5 out of 6 
1 out of 275 
Years Active: 2004-2020
Title: The Innovative Mind of Richard James Lewis
Introduction
Richard James Lewis, a distinguished inventor based in Woolloongabba, Australia, has made significant contributions to science and medicine through his innovative patents. With a remarkable portfolio of ten patents, his work focuses on the application of peptides in treating various medical conditions, particularly those relating to pain management.
Latest Patents
Among his latest patents is the invention regarding **Spider venom peptides and methods of use for modulating sodium channels**. This innovation explores the use of peptides derived from the venom of tarantulas for modulating sodium channels, specifically Na1.7, and addresses conditions associated with Na1.7 activity, such as neuropathic, inflammatory, and nociceptive pain.
Another of his recent advancements involves **Omega conotoxin peptides**. This patent describes an isolated, synthetic, or recombinant peptide with a specified sequence, aimed at enhancing understanding and treatment of various medical conditions. The intricate details of the peptide sequence reflect his deep expertise and innovative approach in the field.
Career Highlights
Throughout his career, Richard has worked with notable institutions, including the University of Queensland and Xenome Limited. His tenure at these organizations has allowed him to further his research and development of groundbreaking inventions in the biomedical field. The combination of his academic background and practical experience has established him as a leading inventor.
Collaborations
Richard has collaborated with esteemed colleagues, including Paul Francis Alewood and Iain Andrew Sharpe. Their joint efforts have propelled advancements in peptide research, showcasing the importance of teamwork in fostering innovation and achieving scientific breakthroughs.
Conclusion
Richard James Lewis exemplifies the spirit of innovation through his extensive work and patents. His dedication to the development of novel treatments is helping to pave the way for advancements in pain management and related medical fields. As research progresses, the impact of his inventions will undoubtedly continue to resonate in both academic and clinical settings.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile